Home > Riviste > Minerva Pediatrica > Fascicoli precedenti > Minerva Pediatrica 2018 February;70(1) > Minerva Pediatrica 2018 February;70(1):107-9

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

LETTERS TO THE EDITOR   

Minerva Pediatrica 2018 February;70(1):107-9

DOI: 10.23736/S0026-4946.16.04778-2

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Teratogenicity of systemic isotretinoin

Helle HOLST 1, 2, Edit MUHARI-STARK 3, Sebastiano A. LAVA 4, 5, 6

1 Department of Clinical Pharmacology, Bispebjerg Hospital, Copenhagen, Denmark; 2 Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 3 Medicines for Children Research Network (MCRN) Hungary, Budapest, Hungary; 4 University Children’s Hospital, Inselspital Bern, University of Bern, Bern, Switzerland; 5 Pediatric Pharmacology and Pharmacogenetics, Hôpital Robert Debré, Paris, France; 6 Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland


PDF


inizio pagina